Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ryokeijutsukanto for Meniere's Disease (RKJKstudy)
jRCTs041200115Completed
- Start
- Dec 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Meniere Disease comparing Ryokeijutsukanto arm with Placebo arm (2 arms). Primary endpoint: Number of vertigo attacks. Started Dec 2021; status: completed.
02
Drugs
ryokeijutsukanto
03
Conditions
Meniere Disease
Beyond the preview
Go deeper on jRCTs041200115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041200115.